Bioventus (BVS) EBITDA Margin (2020 - 2026)
Bioventus (BVS) reported EBITDA Margin of 2.63% for Q1 2026, up 435.0% on a YoY basis from 0.49% in Q1 2025, and down 75.89% quarter-over-quarter from 10.92% in Q4 2025.
Bioventus (BVS) EBITDA Margin (2020 - 2026) Analysis & Trends
Bioventus has reported EBITDA Margin for 7 years, with the latest figure at 2.63% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 435.0% year-over-year to 2.63%; the trailing twelve-month figure through Mar 2026 stood at 5.95% (up 1260.0% YoY), and the FY2025 full-year result was 4.95%, up 1388.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 2.63%, down from 10.92% in the prior quarter.
- The five-year high for EBITDA Margin was 10.92% in Q4 2025, with the low at 116.44% in Q2 2023.
- Historically, EBITDA Margin has averaged 15.35% across 5 years, with a median of 5.29% in 2023.
- Annual changes were most pronounced in 2023 — EBITDA Margin slumped 10670 bps — and 2024, when it surged 11105 bps.
- Bioventus' EBITDA Margin stood at 26.95% in 2022, then surged by 80 bps to 5.29% in 2023, then jumped by 46 bps to 2.83% in 2024, then surged by 486 bps to 10.92% in 2025, then tumbled by 76 bps to 2.63% in 2026.
- The last three EBITDA Margin figures came in at 2.63% (Q1 2026), 10.92% (Q4 2025), and 1.94% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 28.97% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 10.04% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 21.42% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 19.94% |
| 10 | Bioventus | 571.68 Mn | 581.20 Mn | 90.77 Mn | 2.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 2.63% |
| Dec 31, 2025 | 10.92% |
| Sep 27, 2025 | 1.94% |
| Jun 28, 2025 | 7.36% |
| Mar 29, 2025 | -1.72% |
| Dec 31, 2024 | -2.83% |
| Sep 28, 2024 | -3.79% |
| Jun 29, 2024 | -17.21% |
| Mar 30, 2024 | -5.38% |
| Dec 31, 2023 | -5.29% |
| Sep 30, 2023 | -6.27% |
| Jul 1, 2023 | -3.23% |
| Apr 1, 2023 | -116.44% |
| Dec 31, 2022 | -26.95% |
| Oct 1, 2022 | -79.09% |
| Jul 2, 2022 | -5.87% |
| Apr 2, 2022 | -9.73% |
| Dec 31, 2021 | 6.03% |
| Oct 2, 2021 | -2.42% |
| Jul 3, 2021 | -3.74% |